Cortical Inhibition Drives iTBS Efficacy in Treatment-Resistant Depression

Brisbane Convention & Exhibition Centre 

Depression remains a significant global health challenge, with Intermittent Theta Burst Stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC) as a promising intervention for treatment-resistant depression. However, the neurophysiological mechanisms driving its clinical efficacy are not fully understood.